Immunotherapy in Prostate Cancer: Recent Advances and Future Directions

Immunotherapy in Prostate Cancer: Recent Advances and Future Directions

In recent years, immunotherapy has been proposed for the treatment of asymptomatic or minimally symptomatic metastatic castrate-resistant prostate cancer (PCa). Clinical trials using Sipuleucel-T have demonstrated a survival benefit in PCa patients, suggesting that this cancer is linked to a limited...

Full description

Bibliographic Details
Main Authors: Ida Silvestri, Elisabetta Tortorella, Sabrina Giantulli, Susanna Scarpa, Alessandro Sciarra
Format: Article
Language:English
Published: European Medical Journal 2019-05-01
Series:European Medical Journal Urology
Subjects:
chimeric antigen receptor
immune checkpoint inhibitors
immune therapy
prostate cancer
vaccines
Online Access:https://www.emjreviews.com/urology/article/immunotherapy-in-prostate-cancer-recent-advances-and-future-directions/

Internet

https://www.emjreviews.com/urology/article/immunotherapy-in-prostate-cancer-recent-advances-and-future-directions/

Similar Items